DexCom (DXCM) : Shaker Investmentsoh scooped up 11,000 additional shares in DexCom during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 14, 2016. The investment management firm now holds a total of 79,145 shares of DexCom which is valued at $6,188,348.DexCom makes up approximately 5.49% of Shaker Investmentsoh’s portfolio.
Other Hedge Funds, Including , Eqis Capital Management boosted its stake in DXCM in the latest quarter, The investment management firm added 119 additional shares and now holds a total of 7,246 shares of DexCom which is valued at $566,565. DexCom makes up approx 0.04% of Eqis Capital Management’s portfolio.Cutler Group Lp boosted its stake in DXCM in the latest quarter, The investment management firm added 7,997 additional shares and now holds a total of 11,934 shares of DexCom which is valued at $946,724. DexCom makes up approx 0.06% of Cutler Group Lp’s portfolio.Cabot Wealth Management Inc reduced its stake in DXCM by selling 925 shares or 1.9% in the most recent quarter. The Hedge Fund company now holds 47,885 shares of DXCM which is valued at $3,798,717. DexCom makes up approx 0.98% of Cabot Wealth Management Inc’s portfolio.Alpha Windward reduced its stake in DXCM by selling 250 shares or 61.73% in the most recent quarter. The Hedge Fund company now holds 155 shares of DXCM which is valued at $12,225. DexCom makes up approx 0.01% of Alpha Windward’s portfolio. Washington Trust Bank added DXCM to its portfolio by purchasing 26 company shares during the most recent quarter which is valued at $2,051.
DexCom opened for trading at $78.3 and hit $78.52 on the upside on Monday, eventually ending the session at $78.19, with a gain of 0.83% or 0.64 points. The heightened volatility saw the trading volume jump to 11,90,819 shares. Company has a market cap of $6,524 M.
On the company’s financial health, DexCom reported $-0.23 EPS for the quarter, missing the analyst consensus estimate by $ -0.02 based on the information available during the earnings call on Apr 27, 2016. Analyst had a consensus of $-0.21. The company had revenue of $116.20 million for the quarter, compared to analysts expectations of $110.93 million. The company’s revenue was up 59.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.17 EPS.
Dexcom Inc. (Dexcom) is a medical device company. The Company is focused on the design development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4 DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patient’s receiver and an application on the patient’s iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers who can remotely monitor a patient’s glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.